Advanced Biomed Inc.
ADVB
$1.86
-$0.04-2.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -524.85% | 65.56% | 44.50% | 62.30% | |
| Total Depreciation and Amortization | 35.01% | 14.45% | 72.55% | 2,958.33% | |
| Total Amortization of Deferred Charges | -- | -- | -51.83% | -- | |
| Total Other Non-Cash Items | -- | -- | -100.00% | -- | |
| Change in Net Operating Assets | -131.04% | 112.56% | -97.16% | 90.16% | |
| Cash from Operations | -2,554.23% | 95.20% | -542.68% | 110.49% | |
| Capital Expenditure | 122.48% | -- | 93.69% | 68.31% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | 122.48% | -- | 93.37% | 68.31% | |
| Total Debt Issued | -39.40% | 30.68% | -- | 623.94% | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 50.00% | -- | 121.97% | -- | |
| Cash from Financing | -38.87% | 25.32% | 181.73% | 589.27% | |
| Foreign Exchange rate Adjustments | 193.10% | -212.14% | -61.16% | -114.28% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -94.61% | 211.11% | -190.84% | 131.70% | |